Navigation Links
Entest Biomedical Enters into Discussions with Laser Manufacturer to Develop Proprietary Photoceutical Device for COPD Treatment
Date:11/24/2009

Laser-type device to be coupled with Stem Cell Therapy.

San Diego, CA (PRWEB) November 24, 2009 -- Entest Biomedical, Inc. (OTCBB: ENTB) announced that it has initiated discussions with a manufacturer of lasers regarding the development of a proprietary laser device which shall be owned by Entest and used in conjunction with several stem cell therapies currently being developed by Entest. These therapies are aimed at increasing efficacy in treating Chronic Obstructive Pulmonary Disease (COPD). A spokesman for Entest stated that this particular manufacturer was approached due to their success in commercializing medical devices in the North American market.

“Biotechnology R&D companies like Entest frequently have intellectual property tied to medical devices under development. Entest’s planned usage of laser-type devices in treating COPD requires the adaptation of current laser technology into a device that supports the Company’s Stem Cell / Photoceutical therapy.” said David Koos, Chairman and CEO of Entest. “Companies such as PhotoThera in Carlsbad, California, have successfully used this approach in developing their laser-based NeurotheraÒ technology for treating ischemic stroke patients (currently in Phase III clinical trials).”

Entest’s patent-pending approach revolves around the use of the patient’s own stem cells in combination with specific laser wavelengths to repair damaged lung tissue of patients with COPD.

Ernest’s goal is the generation of schematics, code, and intellectual property pertaining to the new device which will serve as the basis for regulatory filings and FDA development of the Entest “regenerative photoceutical” approach to COPD.

About Ent
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment
2. Entest BioMedical, Inc. Discusses How Therapies in Development May Yield Lucrative Revenue Streams for the Company
3. Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
4. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
5. Largest British Fund for Biomedical Research Finances Project on Breakbone Fever in Leuven (K.U.Leuven)
6. Biomedical Research Centre searches for immunological biomarkers
7. Nine International Research Teams Collaborate to Successfully Operate Multiple Biomedical Robots from Numerous Locations
8. Sponsor-A-Scientist: New Option to Fund Biomedical Research
9. Biomedical Research Centre developing enhanced cells as therapies
10. Environmental Tectonics Corporations BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania
11. New test for safer biomedical research results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe’s ... expertise to the Los Angeles County clinics including ... procedures are now being offered at all Healthpointe ... County, and San Bernardino County. , As ... neurons send electrical impulses throughout the body ...
(Date:5/29/2015)... May 29, 2015 The annual aesthetic meeting, ... (ASAPS), was held in Montreal from May 14-19th. This ... aesthetic professionals from around the world; dedicating itself exclusively to ... many renowned plastic surgeons to attend this year’s ... six-day event, Dr. Vitenas was given the honor of sitting ...
(Date:5/29/2015)... The FSH Society , the ... the little-known and incurable disease, facioscapulohumeral muscular dystrophy ... FSHD Trial Preparedness Workshop. The Workshop, being held ... Rochester Medical Center in Rochester, New York, will ... world, including representatives from industry, the Food and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The popular ... of their rewards based L-Style Select Program that gives ... program is limited to only 100 members per year, ... work one on one with fitness experts at Nuretix ... cost to them provided that they attain and maintain ...
(Date:5/29/2015)... NEW YORK (PRWEB) May 29, 2015 ... Medical Center has found that a urine test ... cancer with 92 percent accuracy. Dr. James McKiernan ... 2015 Annual Meeting Press Event. , Dr. ... John K. Lattimer Professor and chair of the ...
Breaking Medicine News(10 mins):Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 2Health News:International Conference Brings Together Key Stakeholders to Advance Clinical Trial Readiness for FSHD 3Health News:Liporidex, a Sports Nutrition Supplement Brand, Is Searching For Members For Their Exclusive L-Style Select Program Which Rewards Members For Their Achievements 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 2Health News:Urine Test Detects Prostate Cancer with 92 Percent Accuracy, According to Study 3
... ... before and after photos , ... 9, 2010 -- HCG True Diet offers new HCG Diet before and after photos and revamped ... navigation bar at the left hand of the site. The photos are taken of a ...
... HealthDay Reporter , THURSDAY, July 8 (HealthDay News) -- The ... smoke has slowed significantly, following dramatic drops starting in the ... percent of high school students still smoke, making it impossible ... among teens to 16 percent or less, the U.S. Centers ...
... ... career opportunities for ambitious professionals. , ... (PRWeb UK) July 9, 2010 -- HCL International, the leading global health and social ... GPs and social workers interested in working in Australia, at an invitation-only ...
... ... discovered a different kind of healing through writing down her emotions , ... Honolulu, HI (Vocus) July 9, 2010 -- She ... the release of Finally, it’s my time!, her new book made available through Xlibris, author ...
... ... new ways to make extra cash without having to spend big dollars. ... and beauty”. While most people cut back on certain luxuries during hard ... the recession. Youthful Trends is an innovative cosmetic company that is banking ...
... obese children have a 40 percent higher risk of ... obese have a 30 percent higher risk of GERD ... Permanente study published online in the International Journal ... establishes an association between obesity and GERD in children, ...
Cached Medicine News:Health News:See New HCG Diet Before and After Photos 2Health News:Decline in U.S. Teen Smoking Rate Stalls 2Health News:Decline in U.S. Teen Smoking Rate Stalls 3Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 2Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 3Health News:Moving On With A Pen 2Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 2Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 3Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 4Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 2Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 3
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and ... AZN ) today announced that they have entered into ... preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, ... VEGF Receptor 2 antiangiogenic cancer medicine. The planned study ... with advanced solid tumors. The Phase I ...
(Date:5/28/2015)... and Company (NYSE: LLY ) announced today the pricing ... to $1.6 billion aggregate principal amount of certain of its ... and did not validly withdraw, their notes on or before ... on May 27, 2015 (the early tender date), and which ... the total consideration. The total consideration for each series of ...
(Date:5/28/2015)... Research and Markets ( ... Jain PharmaBiotech,s new report  "RNAi - Technologies, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the use of double stranded RNA (dsRNA). ... processed into short 21-23 nucleotide RNAs termed ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
... unit provides a convenient reservoir of cooling water for ... an extended period of time or in a location ... cool the hot side of the thermoelectric heat pump. ... which is adequate to run the 900R for up ...
Punch set for Advanced Tissue Arrayer, 0.6 mm...
Inquire...
Inquire...
Medicine Products: